Board of Directors

The CMPI Board of Directors is comprised of some of the nation’s leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.

Peter J. Pitts
President,
Center for Medicine in the Public Interest

Robert M. Goldberg
Vice President & Director of Programs,
Center for Medicine in the Public Interest

Steven Sammut
Lecturer,
Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania

Mark Thornton, M.D., Ph.D.
Chairman and President,
Sarcoma Foundation of America

Michael Weber, M.D.
Professor of Medicine,
SUNY Downstate College of Medicine
Brooklyn, New York
Sign Up for Our Email Newsletter

RECENT NEWS

New Report Demonstrates How Hospitals, Pharmacies & PBMs Exploit the Federal 340B Drug Program to the Harm of Disadvantaged Patients
  • CMPI
  • 09/09/2022 12:00 AM

New Report Demonstrates How Hospitals, Pharmacies & PBMs Exploit the Federal 340B Drug Program to the Harm of Disadvantaged Patients

Nation’s largest hospitals, pharmacy benefit managers (PBMs), and pharmacies abuse drug discount program to pocket saving...  Read more

Peter Pitts on CDC reorganization proposal

Peter Pitts on CDC reorganization proposal

Peter Pitts joins NEWSY to discuss proposed CDC changes...  Read more

Why the FTC is Investigating Pharmacy Benefit Managers

Why the FTC is Investigating Pharmacy Benefit Managers

In money matters, U.S. regulators are investigating claims by PBMs who say they save you money on prescriptions....  Read more

DRUGWONKS BLOG